Brief: Zynerba Pharmaceuticals Reports Q3 Results And Operational Highlights
14/11/2022 17:23
Nov 14 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* QTRLY NET LOSS PER SHARE - BASIC AND DILUTED $0.20
Source text for Eikon: ID:nGNX3LWXG3
Further company coverage: ZYNE.O
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary